Biotech

Biotechnology & Sustainability News

Biotechnology & Sustainability Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 24.02.2022.

#LifeSciencesNews
#PharmiwebNews
#PharmaNews
#MedicalNews
#BiotechNews
#ClinicalResearchNews
#HealthcareNews
#geneticliteracy
#newsletter
#Biotech

Sustainability

@prometheusgreen shared
On Feb 22, 2022
RT @GeneticLiteracy: “Yes, your Highness: GM crops and more recently foods grown using CRISPR, really do benefit us all.” #geneticliteracy https://t.co/nCWK7D81hF
Open
Viewpoint — Prince Charles’ ongoing rejection of GM, biotechnology-inspired crop advances is the latest example of celebrity disinformation on...

Viewpoint — Prince Charles’ ongoing rejection of GM, biotechnology-inspired crop advances is the latest example of celebrity disinformation on...

There are relatively few people in the world who possess sufficient gravitas that the media are prepared to publicize their views on almost anything and

@JonEntine shared
On Feb 18, 2022
Viewpoint: Who are the activists and politicians that led Sri Lanka to reject science and embrace disastrous all-organic farm model? https://t.co/tXBEJj91af via @GeneticLiteracy
Open
Viewpoint: Who are the activists and politicians that led Sri Lanka to reject science and embrace disastrous all-organic farm model?

Viewpoint: Who are the activists and politicians that led Sri Lanka to reject science and embrace disastrous all-organic farm model?

Vandana Shiva, proclaimed "Hero for the Green Century" in 2002 and winner of numerous awards (including the Right Livelyhood Award and the Save the World

@CropLifeIntl shared
On Feb 22, 2022
What you need to know about the UN Environment Assembly @UNEA https://t.co/P6mMxlwFS8
Open
What you need to know about the UN Environment Assembly

What you need to know about the UN Environment Assembly

UNEA-5.2 comes at a critical time for the environment. Multilateral agreements such as those that will be made in Nairobi are vital to tackle global environmental issues.

@GHGGuru shared
On Feb 24, 2022
Surprised? “Ocean Plastic Is Bad, but Soil Plastic Pollution May Be Worse” | CivilEats via https://t.co/61wTvXgXt0
Open
Ocean Plastic Is Bad, but Soil Plastic Pollution May Be Worse

Ocean Plastic Is Bad, but Soil Plastic Pollution May Be Worse

The rise of plasticulture threatens the soil and human health. A new U.N. report spells out what's needed to end it.

@pharminews shared
On Feb 21, 2022
Stanislaus County to Conduct First-Ever Online Tax Sale on Bid4Assets https://t.co/u9paQYgI7x #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/pP2W5pgnHf
Open
Stanislaus County to Conduct First-Ever Online Tax Sale on Bid4Assets

Stanislaus County to Conduct First-Ever Online Tax Sale on Bid4Assets

The online auction will open March 7 with 40 properties listed. 10.96-Acre Biofuels Plant Assessed at $38 million. This property includes substantial fixtures and ...

@pharminews shared
On Feb 23, 2022
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers https://t.co/6farpZstVC #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/yEWmMhAjV7
Open
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers

AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers

AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers  New inhalers would have near-zero Global Warming ...

@pharminews shared
On Feb 23, 2022
Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program https://t.co/9ouHxDZlxv #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/Cm3nYMXY24
Open
Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program

Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program

Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program In a Phase 3 trial in patients refractory to omalizumab, Dupixent did not reach statistical ...

@EuropaBio shared
On Feb 23, 2022
🔊 Looking for something to read during your #lunchbreak 🍱 ?! 📩 Check out our #February #newsletter and get updates on the latest developments in the #Biotech sector: 👉 https://t.co/7TLG6cPmBK ! 🔬 ➡️ ... Don't forget to subscribe: https://t.co/nDl6r3iJMm! https://t.co/cqPCVJcU3I
Open
Policy corner: building a biotechnology ecosystem

Policy corner: building a biotechnology ecosystem

EU Industry Days 2022 | EuropaBio's Director-General, Claire Skentelbery, spoke at the session "Strengthening the European pharmaceutical supply chains: what role for …